Anti-Toxoplasma activity of Sorghum bicolor-derived lipophilic fractions

OBJECTIVE: Toxoplasma gondii, an intracellular zoonotic parasite, infects approximately a third of the world population. Current drugs for treatment of T. gondii infection have been challenged with ineffectiveness and adverse side effects. This necessitates development of new anti-Toxoplasma drugs....

Descripción completa

Detalles Bibliográficos
Autores principales: Abugri, Daniel A., Jaynes, Jesse M., Witola, William H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814109/
https://www.ncbi.nlm.nih.gov/pubmed/31651353
http://dx.doi.org/10.1186/s13104-019-4732-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814109/
https://www.ncbi.nlm.nih.gov/pubmed/31651353
http://dx.doi.org/10.1186/s13104-019-4732-z

Ejemplares similares